News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
259,206 Results
Type
Article (13832)
Company Profile (293)
Press Release (245081)
Section
Business (79305)
Career Advice (147)
Deals (13176)
Drug Delivery (31)
Drug Development (50266)
Employer Resources (31)
FDA (5668)
Job Trends (5110)
News (144023)
Policy (10013)
Tag
Academia (901)
Alliances (21440)
Alzheimer's disease (731)
Approvals (5632)
Artificial intelligence (61)
Bankruptcy (97)
Best Places to Work (4468)
Biotechnology (241)
Breast cancer (57)
Cancer (603)
Cardiovascular disease (52)
Career advice (128)
CAR-T (48)
Cell therapy (156)
Clinical research (39608)
Collaboration (205)
Compensation (85)
COVID-19 (998)
C-suite (58)
Cystic fibrosis (61)
Data (641)
Diabetes (65)
Diagnostics (1191)
Earnings (28677)
Events (46602)
Executive appointments (157)
FDA (5917)
Funding (211)
Gene editing (51)
Gene therapy (130)
GLP-1 (292)
Government (1063)
Healthcare (6528)
Infectious disease (1028)
Inflammatory bowel disease (89)
IPO (7169)
Job creations (859)
Job search strategy (124)
Layoffs (182)
Legal (1372)
Lung cancer (102)
Manufacturing (68)
Medical device (2547)
Medtech (2548)
Mergers & acquisitions (6090)
Metabolic disorders (204)
Neuroscience (913)
NextGen Class of 2024 (1997)
Non-profit (842)
Northern California (810)
Obesity (117)
Opinion (90)
Parkinson's disease (55)
Patents (47)
People (24902)
Pharmaceutical (48)
Phase I (13925)
Phase II (18414)
Phase III (11689)
Pipeline (168)
Postmarket research (846)
Preclinical (5885)
Radiopharmaceuticals (203)
Rare diseases (144)
Real estate (1409)
Regulatory (8166)
Research institute (930)
Southern California (749)
Startups (1963)
United States (6794)
Vaccines (154)
Weight loss (74)
Date
Today (126)
Last 7 days (536)
Last 30 days (1919)
Last 365 days (20586)
2024 (17934)
2023 (22412)
2022 (26822)
2021 (27806)
2020 (23357)
2019 (16224)
2018 (11739)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (146)
Asia (16771)
Australia (2821)
California (1839)
Canada (655)
China (137)
Colorado (70)
Connecticut (72)
Europe (36107)
Florida (198)
Georgia (53)
Illinois (114)
Indiana (53)
Kansas (54)
Maryland (278)
Massachusetts (1536)
Michigan (45)
Minnesota (83)
New Jersey (497)
New York (552)
North Carolina (384)
Northern California (810)
Ohio (73)
Pennsylvania (386)
South America (207)
Southern California (749)
Texas (192)
Washington State (199)
259,206 Results for "lisata therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration
November 6, 2024
·
9 min read
Pharm Country
Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor Events
Lisata Therapeutics, Inc. today announced that management will participate in the following events in June.
May 28, 2024
·
2 min read
Press Releases
Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events
October 31, 2024
·
2 min read
Pharm Country
Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor Events
Lisata Therapeutics, Inc. today announced that management will participate in the following events in May.
May 8, 2024
·
3 min read
Pharm Country
Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic Cancer
Lisata Therapeutics, Inc. today announced that it has reached agreement with the European Medicines Agency (the “EMA”) on a Paediatric Investigation Plan (“PIP”) for Lisata’s lead investigational product, certepetide (formerly LSTA1), in pancreatic cancer.
May 20, 2024
·
7 min read
Drug Development
Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, announced the successful completion of patient enrollment for the pancreatic cancer cohort in the Phase 1b/2a CENDIFOX trial.
June 13, 2024
·
7 min read
Pharm Country
Lisata Therapeutics to Participate in Upcoming April 2024 Industry and Investor Events
Lisata Therapeutics, Inc. today announced that David J. Mazzo, PhD, President and Chief Executive Officer of Lisata, will participate in the following events in April.
April 3, 2024
·
2 min read
Business
Lisata Therapeutics to Participate in Upcoming October 2024 Industry and Investor Events
October 3, 2024
·
2 min read
Press Releases
Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis
October 28, 2024
·
7 min read
Press Releases
Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024
November 6, 2024
·
1 min read
1 of 25,921
Next
